Colestyramine 0.444 g/g (4g anhydrous cholestyramine resin / 9g questran powder) - rezultati pretrage

Australija - engleski - Department of Health (Therapeutic Goods Administration)

ataris 10 leflunomide 10mg tablet bottle

southern cross pharma pty ltd - leflunomide, quantity: 10 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; maize starch; povidone; crospovidone; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000 - treatment of active rheumatoid arthritis.,treatment of active psoriatic arthritis. leflunomide is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. the combined use of leflunomide with other disease modifying antirheumatic drugs (dmards) has not been adequately studied (see precautions).

Australija - engleski - Department of Health (Therapeutic Goods Administration)

valprease 500 sodium valproate 500 mg tablet blister pack

arrotex pharmaceuticals pty ltd - sodium valproate, quantity: 500 mg - tablet, enteric coated - excipient ingredients: triethyl citrate; citric acid; magnesium stearate; sodium starch glycollate; purified talc; povidone; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; xanthan gum; polyvinyl alcohol; lecithin; polysorbate 80; purified water; methacrylic acid copolymer; sodium lauryl sulfate; indigo carmine; sunset yellow fcf; allura red ac; macrogol 3350 - epilepsy. primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.. mania. for the treatment of mania where other therapy has proved inadequate or is inappropriate.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

valprease 200 sodium valproate 200 mg tablet blister pack

arrotex pharmaceuticals pty ltd - sodium valproate, quantity: 200 mg - tablet, enteric coated - excipient ingredients: purified talc; triethyl citrate; sodium starch glycollate; colloidal anhydrous silica; microcrystalline cellulose; povidone; magnesium stearate; citric acid; polysorbate 80; purified water; methacrylic acid copolymer; sodium lauryl sulfate; titanium dioxide; indigo carmine; sunset yellow fcf; allura red ac; polyvinyl alcohol; macrogol 3350; xanthan gum; lecithin - epilepsy. primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.. mania. for the treatment of mania where other therapy has proved inadequate or is inappropriate.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

melobic 15 meloxicam 15 mg tablets blister pack

arrotex pharmaceuticals pty ltd - meloxicam, quantity: 15 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; sodium citrate dihydrate; povidone; crospovidone - meloxicam is indicated for symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

melobic 7.5 meloxicam 7.5 mg tablets blister pack

arrotex pharmaceuticals pty ltd - meloxicam, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; sodium citrate dihydrate; colloidal anhydrous silica; crospovidone; microcrystalline cellulose - meloxicam is indicated for symptomatic treatment of osteoarthritis and rheumatoid arthritis.